Omeros Corporation
OMER
#6343
Rank
NZ$1.37 B
Marketcap
NZ$19.41
Share price
-2.18%
Change (1 day)
25.41%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -NZ$0.21 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$0.27 Billion a decrease over its 2023 earnings that were of -NZ$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.21 Billion-21.09%
2024 -NZ$0.27 Billion9.63%
2023 -NZ$0.24 Billion-9.57%
2022 -NZ$0.27 Billion-30.65%
2021 -NZ$0.39 Billion86.28%
2020 -NZ$0.21 Billion99.45%
2019 -NZ$0.11 Billion-49.91%
2018 -NZ$0.21 Billion190.77%
2017 -NZ$70.49 Million-27.96%
2016 -NZ$97.85 Million-17.61%
2015 -NZ$0.12 Billion1.88%
2014 -NZ$0.12 Billion87.56%
2013 -NZ$62.15 Million
2011 -NZ$45.52 Million-8.96%
2010 -NZ$49.99 Million45.03%
2009 -NZ$34.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.79 B-27,200.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$19.67 B-10,014.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-NZ$6.42 Million-96.77%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-NZ$15.76 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA